|
Gorgojo-Martinez JJ, Gorriz JL, Cebrian-Cuenca A, Castro Conde A, Velasco Arribas M. Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus. J Clin Med. 2024 Oct 30;13(21):6509. doi: 10.3390/jcm13216509. PubMed PMID: 39518647; PubMed Central PMCID: PMC11546491.
AÑO: 2024; IF: 3.0
|
39518647
|
Botana Lopez M, Camafort Babkowski M, Campuzano Ruiz R, Cebrian Cuenca A, Gargallo Fernandez M, David de Paz H, Redondo-Anton J, Artime E, Diaz-Cerezo S, Rubio de Santos M. Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Adv Ther. 2024 Sep;41(9):3569-3584. doi: 10.1007/s12325-024-02938-2. Epub 2024 Jul 22. PubMed PMID: 39039388; PubMed Central PMCID: PMC11349830.
AÑO: 2024; IF: 3.4
|
|
Navarro-Gonzalez JF, Ortiz A, Cebrian Cuenca A, Segu L, Pimentel B, Aranda U, Lopez-Chicheri B, Capel M, Pomares Mallol E, Caudron C, Garcia Sanchez JJ, Alcazar Arroyo R. Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis. Nefrologia (Engl Ed). 2024 Nov-Dec;44(6):857-867. doi: 10.1016/j.nefroe.2024.11.020. Epub 2024 Dec 6. PubMed PMID: 39645514.
AÑO: 2024
|
|
Orozco-Beltran D, Lecumberri-Pascual E, Quesada JA, Moreno-Perez O, Ruiz-Quintero MA, Pomares-Gomez FJ, Jodar-Gimeno E, Pardo-Ruiz C, Mascarell-Martinez I, Mirete-Lopez RM, Morant-Bes B, Borrachero-Guijarro JM, Zapatero-Larrauri M, Aparicio-Egea MC, Paniagua-Merchan C, Requena-Ferrer RM, Caride-Miana E, Fernandez-Gimenez A, Lopez-Pineda A, Nouni-Garcia R, Carratala-Munuera C, Cebrian-Cuenca AM. Psychometric properties of the Clarke questionnaire for hypoglycemia awareness in the Spanish population with type 2 diabetes. Postgrad Med. 2023 Mar;135(2):141-148. doi: 10.1080/00325481.2022.2138469. Epub 2022 Dec 7. PubMed PMID: 36475508.
AÑO: 2023; IF: 2.6
|
|
Lumbreras B, Parker LA, Alonso-Coello P, Mira-Bernabeu J, Gomez-Perez L, Caballero-Romeu JP, Pertusa-Martinez S, Cebrian-Cuenca A, Moral-Pelaez I, Lopez-Garrigos M, Canelo-Aybar C, Ronda E, Guilabert M, Prieto-Gonzalez A, Hernandez-Aguado I. PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study. Int J Environ Res Public Health. 2022 Jul 22;19(15):8904. doi: 10.3390/ijerph19158904. PubMed PMID: 35897274; PubMed Central PMCID: PMC9330901.
AÑO: 2022; IF: 4.614
|